{
    "name": "ganirelix",
    "comment": "Rx",
    "other_names": [
        "Antagon",
        "Orgalutran"
    ],
    "classes": [
        "Gonadotropin Releasing Hormone Antagonists"
    ],
    "source": "https://reference.medscape.com/drug/ganirelix-342757",
    "pregnancy": {
        "common": [
            "Contraindicated in pregnant women"
        ],
        "specific": [
            {
                "type": "Animal data",
                "description": [
                    "When administered from Day 7 to near term to pregnant rats and rabbits at doses up to 10 and 30 mcg/day (~0.4 to 3.2 times the human dose based on body surface area), ganirelix acetate increased the incidence of litter resorption",
                    "There was no increase in fetal abnormalities",
                    "No treatment-related changes in fertility, physical, or behavioral characteristics were observed in the offspring of female rats treated with ganirelix acetate during pregnancy and lactation"
                ]
            }
        ]
    },
    "lactation": {
        "common": [
            "Should not be used by lactating women",
            "Unknown whether drug is excreted in human milk",
            "Consider the developmental and health benefits of breastfeeding along with the motherâ€™s clinical need for the drug, and any potential adverse effects on the breastfed infant from the drug or from the underlying maternal condition"
        ]
    },
    "warnings": {
        "black_box_warning": {
            "common": [],
            "specific": []
        },
        "contraindicators": {
            "common": [
                "Known or suspected pregnancy",
                "Hypersensitivity to ganirelix, LHRH or LHRH analogs"
            ],
            "specific": []
        },
        "cautions": {
            "common": [
                "Exclude pregnancy before initiating therapy",
                "Packaging may contain latex products, which may cause allergic reaction in susceptible patients",
                "Use caution in women with sign and symptoms of active allergic conditions"
            ],
            "specific": []
        }
    },
    "interactions": [],
    "adverse effects": [
        {
            "name": "Abdominal pain",
            "percent": "1"
        },
        {
            "name": "Headache",
            "percent": "3"
        },
        {
            "name": "Injection site recation",
            "percent": "1"
        },
        {
            "name": "Nausea",
            "percent": "1"
        },
        {
            "name": "Ovarian hyperstimulation syndrome",
            "percent": "2"
        },
        {
            "name": "Vaginal bleeding",
            "percent": "2"
        },
        {
            "name": "Pelvic pain",
            "percent": "5"
        },
        {
            "name": "Anaphylactoid reactions",
            "percent": null
        }
    ]
}